Global Chimeric Antigen Receptor (CAR)-T Cell Therapy market research report is a demonstrated source of data and information that gives a telescopic view of the current market trends, situations, opportunities and status. The report endows with the CAGR (compound annual growth rate) value fluctuations for the specific forecasted period which seems to be helpful in deciding costing and investment strategies. Global Chimeric Antigen Receptor (CAR)-T Cell Therapy market report is a specific study of the Global Chimeric Antigen Receptor (CAR)-T Cell Therapy industry which explains what the market definition, classifications, applications, engagements, and global industry trends are. A brilliant team of analysts, experts, statisticians, forecasters and economists has worked rigorously to generate this advanced and all-inclusive market research report.
Data Bridge Market Research analyses the growth rate of chimeric antigen receptor (CAR)-T cell therapy in the forecast period 2023-2030. The expected CAGR of the chimeric antigen receptor (CAR)-T cell therapy market is around 11.8% in the mentioned forecast period. The market was valued at USD 2.19 billion in 2022 and would grow to USD 5.35 billion by 2030.
Download Sample PDF Copy of this Report to understand structure of the complete report (Including Full TOC, Table Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-car-t-cell-therapy-market
Market Definition:
The Chimeric antigen receptor (CAR)-T cell therapy is a kind of therapy wherein T-cells are taken from the patient with the addition of a special protein receptor on the T-cells that attack cancer cells. This therapy is widely used to treat certain blood cancers and is being studied in treating other types of cancer. Millions of CAR-T cells are grown on a large scale in the laboratory and then given to the patient through an infusion.
Key players operating in the chimeric antigen receptor (CAR)-T cell therapy market include:
- Autolus Therapeutics (U.K)
- CARsgen Therapeutics Co.Ltd. (U.K)
- Juno Therapeutics, Inc.(U.S)
- Sorrento Therapeutics, Inc. (U.S)
- bluebird bio, Inc. (U.S)
- CELGENE CORPORATION (U.S)
- Eureka Therapeutics Inc. (U.S)
- Avacta Life Sciences Ltd. (U.K)
- Calyxt Inc.(France)
- Celyad Oncology SA (Belgium)
- Fortress Biotech, Inc (U.S.).
- IMMUNE THERAPEUTICS, INC (U.S.)
- Gilead Sciences, Inc. (U.S.)
- Novartis AG (Switzerland)
- Alaunos Therapeutics, Inc (U.S.).
- Poseida Therapeutics, Inc. (U.S.)
Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Scope:
The chimeric antigen receptor (CAR)-T cell therapy market is segmented on the basis of type, target antigen and therapeutic application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Abecma
- Breyanzi
- Kymriah
- Tecartus
- Yescarta
- Others
Target Antigen
- CD 19
- CD 20
- GD2
- CD22
- CD30
- CD33
- HER1
- HER2
- Meso
- Egfrvlll
- Others
Therapeutic Application
- Acute Lymphocytic Leukemia
- Chronic Lymphocytic Leukemia
- Non-Hodgkin Leukemia
- Multiple Myeloma
- Pancreatic Cancer
- Neuroblasts, Breast Cancer
- Acute Myeloid Leukemia
- Hepatocellular
- Carcinoma
- Colorectal Cancer
- Others
Browse Full Report Along with Facts and Figures @ https://www.databridgemarketresearch.com/reports/global-car-t-cell-therapy-market
Table of Content:
Part 01: Executive Summary
Part 02: Scope of the Report
Part 03: Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Landscape
Part 04: Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Sizing
Part 05: Global Chimeric Antigen Receptor (CAR)-T Cell Therapy Market Segmentation By Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis
Check Complete Table of Contents with List of Table and Figures @ https://www.databridgemarketresearch.com/toc/?dbmr=global-car-t-cell-therapy-market
Browse Trending Reports:
About Data Bridge Market Research:
An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.
Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.
Contact Us: -
Data Bridge Market Research
US: +1 888 387 2818
United Kingdom: +44 208 089 1725
Hong Kong: +852 8192 7475
